The present study is aimed to explore the role of the specific endocannabinoid 2-AG-derived lysophosphatidic acid 2-AGP in the Tau-mediated microtubule assembly and maintenance of axonal homeostasis, and its impairment in AD. Here, MAPT is linked to Alzheimer disease.